KATIA RAYBURN: Open Payments
NPI 1740870583 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 14 payments from 6 companies in 2025. Trend: 2023 $392 · 2024 $569 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $146 |
| Novo Nordisk Inc | 2 | $109 |
| Janssen Scientific Affairs, LLC | 1 | $65 |
| ABBVIE INC. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 5 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: TREMFYA, Wegovy, VOQUEZNA, ZENPEP, UBRELVY, QULIPTA.
Industry payments across AR — which companies pay providers there.
